2023-11-07 21:15:20 ET
Image source: The Motley Fool.
MannKind (NASDAQ: MNKD)
Q3 2023 Earnings Call
Nov 07, 2023 , 5:00 p.m. ET
Operator
For further details see:
MannKind (MNKD) Q3 2023 Earnings Call Transcript2023-11-07 21:15:20 ET
Image source: The Motley Fool.
MannKind (NASDAQ: MNKD)
Q3 2023 Earnings Call
Nov 07, 2023 , 5:00 p.m. ET
Operator
For further details see:
MannKind (MNKD) Q3 2023 Earnings Call TranscriptMarket Wire News is a media platform, the information on this page was provided by Motley Fool via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
Pulmatrix Announces Cross License Agreement and Transfer of Laboratory to MannKind Corporation PR Newswire Cross license involves Pulmatrix iSPERSE™ technology and MannKind's Cricket ® inhalation device. Pulmatrix transferring leased building,...
Immediate opportunity to increase capacity for formulation and early asset development in upgraded Boston area R&D space Non-cash deal includes royalty-free iSPERSE ™ technology license in exchange for access to MannKind’s Cricket ® inhaler ...
2024-05-09 00:15:12 ET Image source: The Motley Fool. MannKind (NASDAQ: MNKD) Q1 2024 Earnings Call May 08, 2024 , 5:00 p.m. ET Operator Continue reading For further details see: MannKind (MNKD) Q1 2024 Earnings Call Transcript